Data-driven Identification for Substance Misuse

Substance-Related Disorders Clinical Trial

Official title:

Data-driven Strategies for Substance Misuse Identification in Hospitalized Patients

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT03833804
• Other study ID #: 2021-0509
• Secondary ID: A534285SMPH/MEDI
• Status: Recruiting
• Phase: N/A
• Start date: February 1, 2023
• Est. completion date: March 30, 2025

Study information

• Verified date: January 2024
• Source: University of Wisconsin, Madison
• Contact: Majid Afshar, MD
• Phone: 3125459462
• Email: majid.afshar[@]wisc.edu
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

The investigators propose to develop an open-source, publicly available machine learning model that health systems could download and apply to their electronic health record data marts to screen for substance misuse in their patients. The investigators hypothesize that the natural language processing algorithm can provide a standardized and interoperable approach for an automated daily screen on all hospitalized patients and provide better implementation fidelity for screening, brief intervention, and referral to treatment.

Description:

In 2016, nearly 30% hospital discharges in the United States (US) had a major diagnostic category for a substance-use related condition. Substance misuse ranks second among principal diagnoses for unplanned 7-day hospital readmission rates. Despite the availability of Screening, Brief Intervention, and Referral to Treatment (SBIRT) interventions, substance misuse is not part of the admission routine and only a minority of patients are screened for substance misuse in the hospital setting. This is particularly problematic, since among hospitalized inpatients, the prevalence of substance misuse is estimated to be as high as 25%, greater than either the general population or outpatient setting. Practical screening methods tailored for the hospital setting are needed. In the advent of Meaningful Use in the electronic health record (EHR), efficiency for alcohol detection may be improved by leveraging data collected during usual care. Documentation of substance use is common and occurs in over 96% of provider admission notes, but their free text format renders them difficult to mine and analyze. Natural Language Processing (NLP) and machine learning are subfields of artificial intelligence (AI) that provide a solution to analyze text data in the EHR to identify substance misuse. Modern NLP has fused with machine learning, another sub-field of artificial intelligence focused on learning from data. In particular, the most powerful NLP methods rely on supervised learning, a type of machine learning that takes advantage of current reference standards to make predictions about unseen cases In the earlier version of an NLP and machine learning tool, the investigators successfully used data from clinical notes collected in the first 24 hours of hospital admission to reach a sensitivity and specificity above 70% for identifying alcohol misuse. With nearly 36 million hospital admissions in 2016, a substance misuse classifier has potential to impact millions. In this study, the aim is to prospectively implement a substance misuse classifier to examine its effectiveness against current practice of all hospitalized adult patients at a tertiary health system. The health system has a mature screening system to examine substance misuse classifier performance against current practice of questionnaire screening. The hypothesis is that the substance misuse classifier may provide a standardized, interoperable, and accurate approach to screen hospitalized patients. Successful implementation of the classifier in hospitalized patients is a step towards an automated and comprehensive universal screening system for substance misuse.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 34800
• Est. completion date: March 30, 2025
• Est. primary completion date: January 30, 2025
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 89 Years

Eligibility

Inclusion Criteria:

• Ages 18 years old to 89 years old
• Inpatient status during hospitalization
• Length of stay greater than 24 hours

Exclusion Criteria:

• Cannot participate in the usual care SBIRT intervention
• Death or obtunded during first 24 hours of admission
• Discharged against medical advice
• Transferred from another acute care hospital
• Transferred to another acute care hospital

Related Conditions & MeSH terms

• Substance Abuse
• Substance Use
• Substance-Related Disorders

Intervention

Other:
• Processing of clinical notes in the EHR data collected during routine care
Clinical notes collected in the first day of hospital admission during usual care as input to natural language processing and machine learning algorithm.

Locations

Country	Name	City	State
United States	Rush University Medical Center	Chicago	Illinois

Sponsors (2)

Lead Sponsor	Collaborator
University of Wisconsin, Madison	Rush University Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (1)

Afshar M, Phillips A, Karnik N, Mueller J, To D, Gonzalez R, Price R, Cooper R, Joyce C, Dligach D. Natural language processing and machine learning to identify alcohol misuse from the electronic health record in trauma patients: development and internal — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Proportion of patients that had a universal screen positive and received SBIRT (screening, brief intervention, or referral to treatment)	The primary outcome is the proportion of patients who received SBIRT after a positive universal screen for being at risk for substance misuse. The design is an interrupted time-series prospective observational study.	54 months
Secondary	All-cause re-hospitalizations following 6-months from the Index hospital encounter	We will compare healthcare utilization outcomes in all patients between pre- and post-periods controlling for all patient demographic and clinical characteristics.	12 months enrollment with 6 months follow-up for rehospitalization

External Links

•   login page but full code not finalized for publishing